Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,023,929
-
Share change
-
-754,233
-
Total reported value
-
$41,659,740
-
Price per share
-
$2.60
-
Number of holders
-
39
-
Value change
-
-$405,063
-
Number of buys
-
19
-
Number of sells
-
12
Institutional Holders of CYTEIR THERAPEUTICS INC - COM (CYTT) as of Q2 2023
As of 30 Jun 2023,
CYTEIR THERAPEUTICS INC - COM (CYTT) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,023,929 shares.
The largest 10 holders included
Novo Holdings A/S, BML Capital Management, LLC, OUP Management Co., LLC, Newtyn Management, LLC, Anson Funds Management LP, FMR LLC, VANGUARD GROUP INC, Western Standard LLC, Laurion Capital Management LP, and Acuitas Investments, LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.